22nd Edition – Versions – Global research collaboration for infectious disease preparednessGLOPID-R

National Research and Innovation Fund for Development (FONRID)

Burkina Faso

Represented by Hamidou H. Tamboura

National Institute of Health, Department of Medical Sciences

Thailand

Represented by Aree Thattiyaphong

Department of Health and Human Services

USA

Represented by Elizabeth Higgs

Bill & Melinda Gates Foundation

USA

Represented by David W. Vaughn

European Commission

Represented by Barbara Kerstiens (DG Research and Innovation)

Wellcome Trust

United Kingdom

Represented by Jeremy Farrar

Secretariat of Government of Science, Technology and Productive Innovation

Argentina

Represented by Diego Galeano

Medical Research Council (MRC)

United Kingdom

Represented by Anna Kinsey

ESSENCE on Health Research Initiative Secretariat (WHO/TDR)

Observer

Represented by Garry Aslanyan

Canadian Institutes of Health Research (CIHR)

Canada

Represented by Charu Kaushic

Research Council of Norway (RCN)

Norway

Represented by Karine Kålsås

National Research Foundation of Korea

Korea

Represented by Choong-Min Ryu

National Council of Science and Technology (CONACYT)

Mexico

Represented by Juan José Serrato

Academy of Scientific Research & Technology (ASRT)

Egypt

Represented by Amr Radwan

National Institute of Health Carlos III (ISCIII)

Spain

Represented by Tomás López-Peña

Butantan Institute

Brazil

Represented by Alexander Precioso

German Federal Ministry of Education and Research (BMBF) / DLR-PT

Germany

Represented by
Dr. Christina Müller

Coalition for Epidemic Preparedness Innovations (CEPI)

Observer

Represented by Richard Hatchett & Frederik Kristensen

Foreign, Commonwealth & Development Office (FCDO)

United Kingdom

Represented by Jo Mulligan

European & Developing Countries Clinical Trials Partnership (EDCTP)

Observer

Represented by Pauline Beattie

African Academy of Sciences (AAS)

Kenya

Represented by TBC

Gavi, the Vaccine Alliance

Observer

Represented by Marta Tufet-Bayona

Japan Agency for Medical Research and Development (AMED)

Japan

Represented by Mitsutoshi Ishida

European Research Infrastructure on Highly Pathogenic Agents (ERINHA)

Observer

Represented by Jonathan Ewbank

Sao Paulo Research Foundation (FAPESP)

Brazil

Represented by Reinaldo Salomao

Fiocruz Institute

Brazil

Represented by Marco Krieger

Ministry of Health

Italy

Represented by Gaetano Guglielmi

World Health Organization (WHO)

Observer

Represented by Ana-Maria Henao-Restrepo

UK Department of Health & Social Care

United Kingdom

Represented by Lucy Chappell

National Council for Science and Technology (NCST)

Rwanda

Represented by Eugene Mutimura

Swiss National Science Foundation (SNSF)

Switzerland

Represented by Matthias Egger

Science for Africa Foundation

Kenya

Represented by Moses Alobo

ANRS | Emerging Infectious Diseases

France

Represented by Yazdan Yazdanpanah

Pasteur Network

France

Represented by Rebecca Grais

South African Medical Research Council (SAMRC)

South Africa

Represented by Mongezi Mdhluli

National Health & Medical Research Council (NHMRC)

Australia

Represented by Adam Chapman

Right Foundation

South Korea

Represented by Hoonsang Lee

Netherlands Organisation for Health research and Development (ZonMw)

Netherlands

Represented by Suzanne Verver

Indian Council of Medical Research (ICMR)

India

Represented by Samiran Panda

Fund for Science, Technology and Innovation (FONSTI)

Cote d’Ivoire

Represented by Annette Ouattara

International Development Research Centre (IDRC)

Canada

Represented by John Dusabe-Richards

Global Outbreak Alert and Response Network (GOARN)

Observer

Represented by Gail Carson

Burkina Faso

Thailand

USA

USA

United Kingdom

Argentina

United Kingdom

Observer

Canada

Norway

Korea

Mexico

Egypt

Spain

Brazil

Germany

Observer

United Kingdom

Observer

Kenya

Observer

Japan

Observer

Brazil

Brazil

Italy

Observer

United Kingdom

Rwanda

Switzerland

Kenya

France

France

South Africa

Australia

South Korea

Netherlands

India

Cote d’Ivoire

Canada

Observer

Latest News & Events

GloPID-R members and observers: Register now for our General Assembly October 24-26, 2023

Countdown to the GloPID-R Africa Hub Launch: August 22-23, 2023 in Cape Town

Living Mapping Review for COVID-19 funded research projects: Final update captures data from 20,000 projects and lays the foundation to build a powerful new research funding tracker

The Lancet publishes commentary about the GloPID-R Funders Living Roadmap & funders highlight the value of this new tool to improve clinical trial coordination

Resources

Research prioritisation: Lessons learnt from developing and applying research priorities during the COVID-19 pandemic

Vaccine manufacturability focused on speed

GloPID-R Funders Living Roadmap for Clinical Trial Coordination

COVID-19 Research Project Tracker